MCL1 and cancer: The 1q gain is found in ~ 25% of cancers and may be selected through increasing dosage of the MDM4 oncogene phenocopying TP53 mutation [66], or of MCL-1 antiapoptotic factor [101] or via upregulation of Notch genes [102].